Рус
Latest news
9/26/2024 Pharmaceutical Drug Production in Russia (August 2024)
In January–August 2024, Russian manufacturers produced 530.7 billion rubles’ worth of finished pharmaceutical drugs (manufacturer’s prices, VAT included), up 16.7% from the same period in 2023.
9/19/2024 Study by RNC Pharma and Medvestnik: 66% of Russian Doctors Support Dress Code Policies, 46% Think No Dress Code Will Not Help Solve Real Issues in Healthcare
Most Russian physicians believe that health facilities should have a dress code policy, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.
9/18/2024 RNC Pharma: After Decrease in June, Average Receipt in Russian Pharmacies Keeps Growing for the Second Month in a Row
In January–August 2024, the average receipt in Russian pharmacies was 688 rubles, up 12% from the same period in 2023. Pharmaceutical drugs account for over 80% of the receipt, contributing to the growth rates.
9/17/2024 RNC Pharma: After Decrease in June, Average Receipt in Russian Pharmacies Keeps Growing for the Second Month in a Row
In January–August 2024, the average receipt in Russian pharmacies was 688 rubles, up 12% from the same period in 2023. Pharmaceutical drugs account for over 80% of the receipt, contributing to the growth rates.
9/13/2024 RNC Pharma: Best-Selling Foreign Veterinary Brands Keep Ranking High Thanks to Online Sales
In January–July 2024, over 25.5 billion rubles’ worth of veterinary drugs were sold on the Russian veterinary retail market (retail prices, VAT included), up 14.7% from January–July 2023.
Our competences
RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.